RHAPSIDO
NDC 0078-1483 · Novartis Pharmaceuticals Corporation
Generic nameremibrutinib
Dosage formTABLET
RouteORAL
Active ingredient(s)REMIBRUTINIB
Strength25 mg/1
Pharmacologic classBruton's Tyrosine Kinase Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA]
Marketing categoryNDA
Packages
0078-1483-20 — 60 TABLET in 1 BOTTLE (0078-1483-20)
0078-1483-92 — 2 BOTTLE in 1 CARTON (0078-1483-92) / 30 TABLET in 1 BOTTLE
0078-1483-93 — 30 TABLET in 1 BOTTLE (0078-1483-93)